 Kaplan Fox Kilsheimer LLP is investigating claims on behalf of investors of Elanco Animal Health Incorporated Elanco or the Company NYSE: ELAN. A complaint has been filed on behalf of investors that purchased or acquired Elanco Animal securities between January 10, 2020 and May 6, 2020, inclusive the Class Period. 